Coronary disease & ACS

Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial

JACC Cardiovasc IntervPublished Secondary analysis of the FAME 3 randomised trial

Authors' conclusion

By measuring the FSS, one can identify 50% of patients who have a similar outcome at 1 year with PCI compared with CABG. Lesions deferred from PCI based on FFR have a low event rate.

Study context

Population
Patients with angiographic 3-vessel coronary artery disease (CAD) eligible for coronary artery bypass grafting (CABG) (FAME 3 trial)
Comparison
Percutaneous coronary intervention (PCI) patients stratified by functional SYNTAX score (FSS) vs angiographic SYNTAX score (SS), each compared with CABG
Methodological detailsprespecified substudy
  • Prespecified substudy

Primary result

As reported in the abstract

Primary endpoint · 1 year

PCI patients with FSS ≤22

50%

Further findings

MI and revascularization among all deferred lesions

MI
0.5%
Revascularization
3.2%

Original publication

Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial. JACC Cardiovasc Interv. Published 11 September 2023. doi:10.1016/j.jcin.2023.06.023

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.